Delivery Order SPE2DB22D1002-SPE2DB25FLFC8
- Not listed
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,009 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the contract. The Defense Logistics Agency is the funding agency for this delivery order placed against an...
- The Defense Logistics Agency awarded a $10,002 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562627840 Quillichew ER 20 MG chewable tablets. Under this order, Amerisourcebergen will deliver 100 units of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by September 7, 2023 to support the Department of Defense's medical supply needs. No major subcontractors or set aside designations were identified. This order was issued...
- The Defense Logistics Agency Troop Support Medical awarded a $1,813.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 20 mg Quillichew ER chewable tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health care programs. Performance will take place in Conshohocken, Pennsylvania over a period of one day from July 20, 2023...
- The Defense Logistics Agency awarded a $2,689 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4,562,179,140 Quillichew ER 30 mg chew tablets. The firm fixed price contract calls for the delivery of 100 boxes of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency serving as the contracting agency. No additional details were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ten thousand twenty-seven dollars and twenty-seven cents ($10,027.27) to Amerisourcebergen Drug Corporation for the supply of one hundred (100) boxes of twenty (20) milligram Quillichew ER chewable tablets. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 29, 2023. As a major component of the Defense Department that manages global logistics operations for the...
- The Defense Logistics Agency Troop Support Medical awarded a $4,351 delivery order to Amerisourcebergen Drug Corporation for 4561419800 Quillichew ER chew tabs 40mg. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by July 7, 2023, with performance beginning on July 6. Amerisourcebergen will fulfill the order as the prime contractor from its Corporate Office Division. The Defense Logistics Agency supports Department of Defense health care programs...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,088.72 to AmerisourceBergen Drug Corp for Quillichew ER Chew Tabs 40mg, a medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 100 Quillichew ER 20 mg chew tablets for $1,009.08. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 3, 2023. No set-aside designation was applied to this order, which was awarded against an indefinite delivery contract held by Amerisourcebergen to provide pharmaceuticals and medical...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFC8Delivery Order
The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that serves as the primary pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical procurement supply chain through its established relationship with the Defense Logistics Agency. The company's extensive portfolio of delivery orders demonstrates its capability to supply a broad range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems. This particular order for Quillichew ER, a medication used in attention and concentration disorders, reflects the company's ongoing commitment to providing specialized medications required by the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/22/25 |